Insiders Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
0.9009 ^USD	-5.38%		+38.60%	-1.27%

06-25	Oppenheimer Initiates Gossamer Bio at Outperform With $9 Price Target	MT
06-12	Transcript : Gossamer Bio, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 01:20 PM

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Gossamer Bio Announces Board of Directors Appointments	03-12	CI
Gossamer Bio Inc. Appoints Bob Smith as Chief Commercial Officer	12-05	CI
Gossamer Bio, Inc. Appoints John Quisel to Its Board of Directors	11-29	CI
Gossamer Bio, Inc. Announces Resignation of Kristina Burow from the Board of Directors	07/09/23	CI
Insider Buy: Gossamer Bio	15/07/22	MT
Insider Sell: Gossamer Bio	24/03/22	MT
Gossamer Bio : Names Bryan Giraudo as Operations Chief	21/09/21	MT
Gossamer Bio Appoints Bryan Giraudo as Chief Operating Officer	21/09/21	CI
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer	21/06/21	CI
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors	14/06/21	CI
Gossamer Bio, Inc. Announces Chief Scientific Officer Changes, Effective April 30, 2021	20/04/21	CI
Gossamer Bio, Inc. Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs	16/04/21	CI
Gossamer Bio, Inc. Announces Executive Changes	17/11/20	CI
Gossamer Bio : Appoints Chairman Faheem Hasnain as CEO	16/11/20	MT
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer	16/11/20	CI
Gossamer Bio, Inc. Announces Departure of Otello Stampacchia from its Board of Directors	13/09/19	CI
Gossamer Bio, Inc. Announces the Cessation of Faheem Hasnain as Executive Chairman and Transition to the Role of Non-Executive Chairman of the Board, Effective June 3, 2019	30/05/19	CI
Gossamer Bio, Inc. Announces Executive Changes	19/12/18	CI
Gossamer Bio, Inc. Announces Appointment of Jakob Dupont as Chief Medical Officer	17/12/18	CI
Gossamer Bio, Inc. Bio Announces Appointment of Luisa Salter-Cid as Chief Scientific Officer	05/09/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Insiders

Filters